Clinical Manifestations of Myasthenia Gravis

Update Item Information
Identifier 20000330_nanos_disorderssynapsesympos_02
Title Clinical Manifestations of Myasthenia Gravis
Creator Norah S. Lincoff
Subject Myasthenia Gravis; Clinical Manifestations; Ocular Signs; Systemic Signs; Management; Treatment
Description Myasthenia Gravis (MG) is an autoimmune disorder of neuromuscular transmission in which acetylcholine receptor antibodies attack the postsynaptic membrane of the neuromuscular junction. Reduction in the number of acetylcholine receptors and structural damage to the membrane impair synaptic transmission from motor axons to muscle and result in the weakness and fatigability that characterize this disease. The muscle weakness worsens with exertion or sustained activity. MG can weaken any striated voluntary muscles, and may produce life-threatening symptoms such as dysphagia and respiratory failure. Fortunately therapeutic advances have increased patients' survival and life expectancy.
Date 1999-03-18
Language eng
Format application/pdf
Format Creation application/pdf
Type Text
Source 2000 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2000: Disorders of the Synapse
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2000. For further information regarding the rights to this collection, please visit:
ARK ark:/87278/s68s7wjh
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection:
Contributor Primary Jacqueline A. Leavitt, MD; Barry Skarf, MD, PhD
Setname ehsl_novel_nam
ID 182403
Reference URL
Back to Search Results